NCT04926506View on ClinicalTrials.gov

Efficacy and Safety of Intramuscular Injection of Xiyanping Injection in the Treatment of Acute Bronchitis in Children

NAUnknownINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

October 8, 2021

Primary Completion Date

September 21, 2022

Study Completion Date

December 30, 2022

Conditions
Acute Bronchitis in Children
Interventions
DRUG

Xiyanping injection

Intramuscular injection of Xiyanping injection, 0.3mL / (kg.d) daily, Bid

Sponsors
All Listed Sponsors
lead

Jiangxi Qingfeng Pharmaceutical Co. Ltd.

INDUSTRY

NCT04926506 - Efficacy and Safety of Intramuscular Injection of Xiyanping Injection in the Treatment of Acute Bronchitis in Children | Biotech Hunter | Biotech Hunter